
Silk Road Medical, Inc SILK
Quarterly report 2024-Q2
added 05-16-2026
Silk Road Medical, Inc Total Current Liabilities 2011-2026 | SILK
Annual Total Current Liabilities Silk Road Medical, Inc
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30.3 M | 24.5 M | 26.1 M | 19.6 M | 16.9 M | 10.7 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 30.3 M | 10.7 M | 21.3 M |
Total Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Cutera
CUTR
|
87.7 M | - | -10.19 % | $ 1.99 M | ||
|
EDAP TMS S.A.
EDAP
|
37.8 M | - | - | $ 162 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B | ||
|
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
45.8 M | - | - | $ 3.31 B | ||
|
Eargo
EAR
|
25.3 M | - | - | $ 10.2 M | ||
|
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | ||
|
ClearPoint Neuro
CLPT
|
10.8 M | $ 13.75 | 1.18 % | $ 389 M | ||
|
Apollo Endosurgery
APEN
|
39.5 M | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
219 M | $ 8.13 | -1.57 % | $ 1.22 B | ||
|
Aziyo Biologics
AZYO
|
25.1 M | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
42.8 M | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
19.7 M | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | ||
|
IRIDEX Corporation
IRIX
|
13.2 M | $ 1.13 | 0.89 % | $ 19.1 M | ||
|
Cardiovascular Systems
CSII
|
40 M | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
3.02 M | $ 1.41 | -4.73 % | $ 31.1 M | ||
|
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | ||
|
LivaNova PLC
LIVN
|
808 M | $ 78.38 | 1.57 % | $ 4.28 B | ||
|
Cytosorbents Corporation
CTSO
|
9.71 M | $ 0.41 | -2.72 % | $ 25.5 M | ||
|
Pulmonx Corporation
LUNG
|
20.1 M | $ 1.43 | -6.54 % | $ 58.2 M | ||
|
OrthoPediatrics Corp.
KIDS
|
46.2 M | $ 18.46 | -0.16 % | $ 433 M | ||
|
Delcath Systems
DCTH
|
11 M | $ 11.19 | -4.28 % | $ 401 M | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | ||
|
Orthofix Medical
OFIX
|
170 M | $ 9.73 | -1.42 % | $ 385 M | ||
|
LENSAR
LNSR
|
40.6 M | $ 5.68 | -0.18 % | $ 67.9 M | ||
|
Dynatronics Corporation
DYNT
|
8.24 M | - | 14.99 % | $ 929 K | ||
|
Electromed
ELMD
|
10.5 M | $ 37.18 | 2.17 % | $ 314 M | ||
|
MiMedx Group
MDXG
|
64.3 M | $ 3.64 | -1.89 % | $ 538 M | ||
|
Butterfly Network
BFLY
|
65.1 M | $ 5.39 | 5.07 % | $ 1.33 B | ||
|
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
6.6 M | - | -0.97 % | $ 54.4 M | ||
|
Myomo
MYO
|
8.35 M | $ 1.54 | 16.67 % | $ 64.5 M | ||
|
GBS
GBS
|
5.35 M | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
498 M | $ 80.86 | -2.01 % | $ 10.9 B | ||
|
Insulet Corporation
PODD
|
680 M | $ 150.71 | -5.58 % | $ 10.6 B | ||
|
Profound Medical Corp.
PROF
|
6.08 M | $ 6.71 | -1.61 % | $ 203 M | ||
|
CONMED Corporation
CNMD
|
315 M | $ 36.3 | -1.63 % | $ 1.13 B | ||
|
Inspire Medical Systems
INSP
|
96.1 M | $ 42.28 | 0.17 % | $ 1.24 B | ||
|
Integer Holdings Corporation
ITGR
|
232 M | $ 91.37 | -2.9 % | $ 3.17 B | ||
|
Invacare Corporation
IVC
|
220 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
1.81 B | $ 85.98 | -1.78 % | $ 50.3 B | ||
|
Sintx Technologies
SINT
|
3.73 M | $ 2.07 | -2.13 % | $ 5.74 M |